Corporate Fact Sheet

Offices

61 Moulton Street
Cambridge, MA 02138
e-mail: info@curis.com
URL: www.curis.com
Phone: 617-503-6500
Fax: 617-503-6501

Business

Bio-pharmaceuticals

Management Team

Daniel R. Passeri, President and Chief Executive Officer

Lee L. Rubin, Ph.D., Senior Vice President, Research, and Chief Scientific Officer

Michael P. Gray, M.B.A., CPA., Vice President of Finance and Chief Financial Officer

Mark W. Noel, Vice President, Technology Management and Business Development

M. Elizabeth Potthoff, Esq., Vice President and General Counsel

Board of Directors

James R. McNab, Jr. - Chairman of the Board

Susan B. Bayh

Joseph M. Davie, Ph.D., M.D.

Martyn D. Greenacre

Kenneth I Kaitin, Ph.D.

Douglas A. Melton, Ph.D.

Daniel R. Passeri

James R. Tobin

Founded

August 2000

Ownership

Publicly traded on the NASDAQ (CRIS)

Shares

47, 880, 127 (March 8, 2005)

Employees

64

Partnerships

CURIS corporate partnerships include Ortho Biotech (Johnson & Johnson) for kidney disease and stroke, Genentech for oncology, and Wyeth for neurology.

Transfer Agent

Mellon Investor Service LLC
85 Challenger Road
Ridgefield Park, NJ 07660
Phone: 800-288-9541
www.mellon-investor.com

 

Please see Curis' 10K for specifics of the company and its status based on filing date.